Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP67 is a *pseudogene* of the 7SK small nuclear RNA (7SK snRNA) family, annotated as "RNA, 7SK small nuclear pseudogene 67." Unlike the canonical functional 7SK snRNA, which is an abundant non-coding RNA playing a major role in regulating the positive transcription elongation factor b (P-TEFb) and thus RNA polymerase II–mediated transcriptional elongation[1][2], pseudogenes like RN7SKP67 arise from gene duplication or retrotransposition events but have lost their capacity to encode functional RNA molecules or proteins. There is no current evidence that RN7SKP67 is transcribed into a functional RNA, participates in biological processes, serves as a drug target, or acts as a biomarker. There is no role of RN7SKP67 in disease, interaction with any drugs, or known therapeutic impact. RN7SKP67 should not be confused with the functional gene encoding 7SK snRNA (commonly called SNORD7SK or just 7SK) involved directly in regulation of transcription and RNA processing[1][2]. As a pseudogene, RN7SKP67 is not a therapeutic or pharmacological target, nor is it involved in signaling, enzymatic activity, or transcription factor complexes. No recognized disease role, interacting drugs, or mechanism of action ascribed to it in scientific literature or therapeutic databases[3]. Summary of key points: - **RN7SKP67** is a nonfunctional, processed pseudogene. - It is **not a drug target** or a functional biological molecule. - Any references linking "RN7SKP67" to therapeutic effects or pathways are factually incorrect. - Information for structured target databases should flag **is_incorrect: true** due to its pseudogene status[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 67 (RN7SKP67).